4D pharma plc (LON: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, has today announced that David Norwood, Duncan Peyton and Alex Stevenson have purchased ordinary shares in the Company

4D pharma plc (LON: DDDD), a pharmaceutical company focusing on the development of live biotherapeutics, today announced the final results for the Group for the year ended 31 December 2018.

Could the final frontier of medicine actually be inside us already? New research like that presented at the recent Gut Microbiota for Health World Summit, organised in part by the

4D pharma plc (LON: DDDD), a pharmaceutical company focusing on the development of Live Biotherapeutics, today announced that data from the completed Phase Ib clinical study of Thetanix® for the

E171 is a food additive that manufacturers use to whiten various products, including chewing gum, cake icing, and candy, for instance. While the addition of this substance may render certain

4D pharma plc (LON: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announces its participation in the Neuro4D conference, Frankfurt, Germany, 13-14 May, 2019. Alex Stevenson, 4D’s

Irritable bowel syndrome, or IBS, is one of those health conditions that can be difficult to talk about. And when you are struggling with things like diarrhea, constipation, gas, and

4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announces its participation in the inaugural Chardan Capital Markets LLC Microbiome Medicines Summit. Alex Stevenson,

Bloating is commonly caused by excess wind, which the gut produces when it struggles to break down certain foods. Beans, onions, broccoli and cauliflower, are just some of the foods

4D pharma plc (LON: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announces an update on the clinical progress of its lead oncology Live Biotherapeutic, MRx0518. Duncan